Medpace director granted options on 1,110 shares
Medpace Holdings, Inc. director Brian T. Carley reported an equity compensation award and updated holdings.
Rhea-AI Filing Summary
Medpace Holdings, Inc. director Brian T. Carley reported an equity compensation award and updated holdings. He received a grant of stock options covering 1,110 shares of common stock with an exercise price of $415.27 per share, expiring on May 15, 2033.
The option vests on the earlier of the day immediately before the first Medpace annual meeting after the grant date or the first anniversary of the grant, subject to his continued service on the board. Following the reported transactions, Carley directly holds 32,789 shares of Medpace common stock and 1,110 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,110 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
exercise price financial
vesting financial
board of directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Medpace (MEDP) director Brian T. Carley report?
What is the exercise price and term of Brian Carley’s new Medpace (MEDP) stock options?
How and when do Brian Carley’s Medpace (MEDP) stock options vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.